EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating the Trichosanthis Pericarpium - Trichosanthis Radix herbal pair’s role in alleviating COPD through gut microbiota function, metabolomics analysis and cell validation experiment

Yushan Zhao, Xiaoying Tan, Tian Wang, Yuxuan Yuan, Kelei Su, Erxin Shang, Qingling Xiao, Sheng Guo, Shulan Su, Huangqin Zhang, Jin-Ao Duan, Pei Liu iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0330621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Yushan Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Provincial Key Laboratory of Functional Substances in Traditional Chinese Medicine Formulae and Innovative Drug Discovery, Jiangsu Collaborat…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Gastrointestinal Microbiome, Drugs, Chinese Herbal, Trichosanthes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Scientific Research Project of “Leading Program” by First-class Discipline of NJUCM, Regional Innovation and Development Joint Fund of National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The herbal pair of Trichosanthis Pericarpium – Trichosanthis Radix (TP-TR) is derived from the classic prescription Bei-Mu-Gua-Lou-San in Yixue Xinwu, which is commonly used to treat lung heat and cough. Both originate from Trichosanthes kirilowii Maxim, a medicinal plant known for its effects to clear heat, dissolve phlegm, promote salivation, and relieve dryness. However, the compatibility, pharmacological synergy and gut-lung axis regulation mechanisms of TP-TR remain unclear. This study innovatively explores the therapeutic effects and underlying mechanisms of TP-TR in COPD through microbiome and amino acid metabolism. A COPD rat model was established to evaluate the efficacy of TP-TR. The gut microbiota was analyzed with 16S rRNA sequencing, while the metabolites in serum and lung were analyzed by UPLC-MS/MS. Functional prediction of the microbiome and differential metabolite analysis were performed using KEGG/SMP. The LPS, CSE – induced cell model was used to validate the impact of TP-TR and its active components on amino acid metabolism. The results demonstrated that TP-TR significantly improved pulmonary function, alleviated inflammation, modulated gut microbiota composition (e.g., Lactobacillus , g_ Novosphingobium ), and regulated metabolic disturbances in COPD rats. Notably, amino acid metabolic pathways were consistently enriched across microbiota function prediction and untargeted metabolomic analyses of serum and lung. Targeted metabolomics further confirmed alterations in amino acid levels. Moreover, TP-TR, along with cucurbitacin B, cynaroside, glutamine, guanine, and apigenin induced alterations in the amino acid content of model cells. These findings reveal a novel mechanism by which TP-TR ameliorates COPD through gut microbiota regulation and amino acid metabolism modulation along the gut-lung axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveGastrointestinal MicrobiomeDrugs, Chinese HerbalTrichosanthesAnimalsRatsMetabolomicsMaleRats, Sprague-DawleyHumansLungDisease Models, AnimalRNA, Ribosomal, 16S

Substanzen

Drugs, Chinese HerbalRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Jiangsu Provincial Key Laboratory of Functional Substances in Traditional Chinese Medicine Formulae and Innovative Drug Discovery, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization…
  • Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
  • State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, China.

ORCID-Profile: Pei Liu

Förderung

  • National Natural Science Foundation of China
  • Scientific Research Project of “Leading Program” by First-class Discipline of NJUCM
  • Regional Innovation and Development Joint Fund of National Natural Science Foundation of China
  • High Level Key Discipline Construction Project of the National Administration of Traditional Chinese Medicine - Resource Chemistry of Chinese Medicinal Materia…
  • Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
  • the Six Talents Peaks Project
  • the Major Projects of Natural Science Foundation of Universities in Jiangsu Province

Zitieren

APA

Zhao, Y., Tan, X., Wang, T., Yuan, Y., Su, K., Shang, E., Xiao, Q., Guo, S., Su, S., Zhang, H., Duan, J. A., & Liu, P. (2025). Investigating the Trichosanthis Pericarpium - Trichosanthis Radix herbal pair’s role in alleviating COPD through gut microbiota function, metabolomics analysis and cell validation experiment. PLOS One. https://doi.org/10.1371/journal.pone.0330621

Vancouver

Zhao Y, Tan X, Wang T, Yuan Y, Su K, Shang E, et al. Investigating the Trichosanthis Pericarpium - Trichosanthis Radix herbal pair’s role in alleviating COPD through gut microbiota function, metabolomics analysis and cell validation experiment. PLOS One. 2025. doi:10.1371/journal.pone.0330621

BibTeX
@article{Zhao2025,
  author = {Zhao, Yushan and Tan, Xiaoying and Wang, Tian and Yuan, Yuxuan and Su, Kelei and Shang, Erxin and Xiao, Qingling and Guo, Sheng and Su, Shulan and Zhang, Huangqin and Duan, Jin-Ao and Liu, Pei},
  title = {Investigating the Trichosanthis Pericarpium - Trichosanthis Radix herbal pair’s role in alleviating COPD through gut microbiota function, metabolomics analysis and cell validation experiment},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0330621}
}
Kostenlos starten →